Authors' reply
BMJ 1995; 311 doi: https://doi.org/10.1136/bmj.311.7016.1369b (Published 18 November 1995) Cite this as: BMJ 1995;311:1369- R H Vander Stichele,
- M G Bogaert
- General practitioner Clinical pharmacologist Heymans Institute of Pharmacology, De Pintelaan 185, 9000 Ghent, Belgium
EDITOR,--Both Manice Stallbaumer and colleagues and Ian F Burgess point out the potential or inevitable development of resistance to broadly used pediculicides, which makes extrapolation of results of studies performed in one country to another country hazardous. Indeed, since we completed our manuscript reports of resistance to permethrin have been published.1 2
We agree that a strategy for containing the pandemic of head lice should be based on the use of several active ingredients of proved efficacy. Hence we deplore …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.